Joint Clinical Assessment (JCA) in the EU: The European Commission adopted the Implementing Act on Joint Clinical Assessment
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable step forward in assessing innovative
Germany’s New 2024 Medical Research Act Law
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug pricing and reimbursement laws as
2024 List and Net Pricing Strategies EU-5
What you need to know about confidential discounts and net prices in EU-5 In the EU-5 (France, Germany, Italy, Spain,
Key insights from the new draft regulation on the communication with the European Medicines Agency
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part of the European-wide Health Technology
Il Programma di Accesso Precoce in Francia 2024 copre oltre 330 trattamenti innovativi
In Francia, i Programmi di Accesso Precoce Rimborsati (EAP) consentono il rimborso di nuovi farmaci e medicine prima di quello
L’Inflation Reduction Act degli Stati Uniti: le principali modifiche da conoscere riguardo a prezzi e rimborsi dei farmaci negli USA
L’Inflation Reduction Act (IRA), entrato in vigore nell’agosto del 2022, è una legge che mira ad affrontare diverse questioni critiche
